Plain-English translation of NCT03815006 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 1 diabetes research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial examined whether using FreeStyle Libre 2—a small sensor worn on the arm that continuously reads glucose levels—helped adults with type 1 diabetes achieve better blood sugar control than traditional finger-prick testing over 24 weeks. Participants either used the sensor continuously or continued with fingerstick monitoring, with support from the research team to help improve their diabetes management.
Many people with type 1 diabetes struggle to keep their blood sugar in a healthy range using traditional finger-prick testing alone. This treatment was being tested to see if a device that continuously monitors glucose without fingersticks could make it easier for people to manage their diabetes and achieve better control.
Participants attended up to 7 study visits over 30 weeks at one of eight UK hospital centres. Half of the participants wore the FreeStyle Libre 2 sensor continuously for 24 weeks and received training on how to use it, while the other half continued using fingerstick testing (and wore a hidden sensor for two weeks at the end to measure results). Both groups had blood tests to measure their blood sugar control and received support to help improve their diabetes management.
AI-generated summary from trial data · Oct 11, 2026 · Not medical advice
United Kingdom